Review Article

An Overview of Systematic Reviews of Using Chinese Medicine to Treat Polycystic Ovary Syndrome

Table 7

GRADE quality-of-evidence ratings for testosterone level.

Included systematic reviewsNumber of studies includedTestosterone effect (95% CI)GRADE quality of evidenceRelegation factors

Xiao Chao 2016 [24]8SMD = –0.81, 95% CI (–1.46, –0.16)Very low①②④⑤
Yuan BoChao 2019 [25]5MD = –1.51, 95% CI (–1.64, –1.37)Very low①④⑤
Ji Lin 2019 [26]24SMD = –0.64, 95% CI (–0.97, –0.36)Very low①②⑤
Xie Peng Peng et al 2019 [27]13WMD = –0.93, 95% CI (–1.38, –0.28)Very low①②④⑤
ZhongYizheng et al. 2019 [28]9SMD = –1.59, 95% CI (–1.76, –1.41)Very low①②④
Dong YuFang 2020 [29]37SMD = –0.40, 95% CI (–0.65, –0.15)Very low①②④
Li Nan et al. 2020 [30]3SMD = –0.68, 95% CI (–3.99, 2.62)Very low①②④⑤
Du Xiu et al. 2020 [31]5RR = –0.53, 95% CI (–0.90, –0.16)Very low①②④
Lin BeiBei 2020 [32]19SMD = –0.20, 95% CI (–0.55, 0.16)Very low①②④⑤
Chen JinMing et al. 2020 [33]2MD = 0.95, 95% CI (0.15, 1.75)Very low①②④⑤

Note. CI: confidence interval; MD: mean difference; SMD: standardized mean difference; WMD: weighted mean difference; ①: limitation; ②: inconsistency; ③: indirectness; ④: publication bias; ⑤: imprecision.